Skip to main navigation Skip to search Skip to main content

Giant cell tumors of bone

Research output: Contribution to journalArticlepeer-review

Abstract

The clinical picture and histological evolution of a giant cell tumor of bone (GCT) are mysterious and may be unpredictable. The microscopic diagnosis can be difficult because of secondary xanthomatous and fibromatous changes. The histological classification of Sanerkin is based on sarcomatous changes, the number of mitoses and atypical mitoses and infiltration of the tumor into the vessels. These bone tumors are classified as benign, malignant or borderline according to their clinical behavior. GCT constitute 4% of all bone tumors and 87% of them are localized in the metaphysis of long bones. They are particularly frequent about the knee joint. The differential diagnosis is between GCT and other pathological conditions which include giant cells. Close collaboration between the clinician, the radiologist and the pathologist is necessary for diagnosis. Treatment is mainly surgical, but arterial embolization of the tumor, freezing or radiotherapy have been successful in some cases.

Original languageEnglish
Pages (from-to)231-233+271
JournalHarefuah
Volume107
Issue number9
StatePublished - 1 Dec 1984

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Giant cell tumors of bone'. Together they form a unique fingerprint.

Cite this